by Lindsey Shapiro, PhD | July 27, 2023 For the first time, multiple sclerosis (MS) therapies have been added to the World Health Organization (WHO)’s Model Lists of Essential Medicines (EML), which names those regarded as meeting the most important needs of healthcare systems worldwide. Glatiramer acetate (sold as Copaxone with generics available), Mavenclad (cladribine) and rituximab made the list because of their ability...
Yet another summer COVID wave may have started in the U.S., according to the CDC
Rob Stein, July 27, 20235:51 PM ET Heard on All Things Considered COVID infections, hospitalizations and emergency room visits appear to have ticked up for the first time in 2023. JUANA SUMMERS, HOST: Yet another summer wave of COVID infections may have started. That is according to the latest data from the Centers for Disease...
Commonly used gout drug found effective against COVID-19
by David Mitchell, University of Georgia Time to viral load clearance. Shown is a Kaplan–Meier plot with 95% Hall–Wellner bands of time to clearance of SARS-CoV-2 RNA by treatment. Quartiles are derived from Kaplan–Meier product limit estimates. P-value is based on the Log-Rank test for comparing between treatment groups. Credit: Viruses (2023). DOI: 10.3390/v15071508 An anti-inflammatory drug commonly...
Pitt and UPMC researchers study a better way to test for — and treat — acute sinusitis in kids
ALLIE MILLER Pittsburgh Post-Gazette JUL 27, 2023 8:01 AM One of the most common diseases seen in children is acute sinusitis, which tends to be treated with antibiotics. A new study by researchers at the University of Pittsburgh and UPMC explored a way to limit antibiotic use, which comes with potential side effects, to those young patients who would...
Mysterious meat allergy passed by ticks may affect hundreds of thousands in US, CDC estimates
By Brenda Goodman, CNN Published 1:04 PM EDT, Thu July 27, 2023 Lone star ticks can transmit a sugar called alpha-gal in their saliva that gives people an allergy to red meat.BSIP/Universal Images Group via Getty Images/FILECNN — Ken McCullick died in an emergency room on August 12, 2021. “I got lucky and there was this...
What AI Can See in CT Scans That Humans Can’t
F. Perry Wilson, MD, MSCE July 25, 2023 Welcome to Impact Factor, your weekly dose of commentary on a new medical study. I’m Dr F. Perry Wilson of the Yale School of Medicine. If a picture is worth a thousand words, then a CT scan of the chest might as well be Atlas Shrugged. When you think of the sheer information...
FDA Approves New Device for Enlarged Prostate Treatment
Marcus A. Banks July 11, 2023 The US Food and Drug Administration has approved a new catheter designed to treat urinary tract symptoms of an enlarged prostate, also known as benign prostate hyperplasia (BPH). Designed and marketed by Urotronic (Plymouth, Minnesota), the Optilume BPH Catheter System employs mechanical dilation to relieve obstruction of the prostate and then...
Are You Misdiagnosing IBS? Watch Out for This Mimic
Nick Tate March 10, 2023 UPDATED May 25, 2023 // Editor’s note: This story has been updated to address issues regarding confidentiality of a source. Could an allergy be the real culprit behind gastrointestinal symptoms similar to irritable bowel syndrome (IBS)? For at least some patients, the surprising answer is: Yes. That’s the conclusion of New York gastroenterologist Yevgenia Pashinsky,...
They took blockbuster drugs for weight loss and diabetes. Now their stomachs are paralyzed
By Brenda Goodman, CNN Updated 3:27 PM EDT, Tue July 25, 2023 Joanie Knight has a message for anyone considering drugs like Ozempic or Wegovy, which have become popular for the dramatic weight loss they can help people achieve. “I wish I never touched it. I wish I’d never heard of it in my life,”...
Another win for Novo’s semaglutide? Physicians prefer it most in the emerging field of NASH treatments, survey finds
Beth Snyder BulikSenior EditorAs fatty liver disease gets a new name, will it also finally get approved drug treatments? That’s what healthcare professionals are hoping for as nonalcoholic fatty liver disease (NAFLD) becomes metabolic dysfunction-associated fatty liver disease (MAFLD), and nonalcoholic steatohepatitis (NASH) becomes metabolic dysfunction-associated steatohepatitis (MASH). The name changes, aimed at getting rid...